Q2 FY26 results: revenue and profit decline, board reallocates QIP funds to Dahej
LXCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Laxmi Organic Q2 FY26 standalone revenue fell about 5 percent YoY to Rs 7,064 million; H1 revenue Rs 13,783 million vs Rs 14,625 million. Standalone PAT dropped to Rs 139 million (Q2) and Rs 369 million (H1) from Rs 265 million and Rs 617 million. Board reallocated about Rs 346 million of QIP proceeds to the Dahej Project (deadline now June 2026) from Mahape Innovation Centre. Re-appointed Dr. Rajeev Vaidya as Independent Director for 3 more years.
Weak quarter with lower revenue and profit; QIP fund shift extends Dahej Project timeline to June 2026.